Estimates Revisions Relay Therapeutics, Inc.
Stocks
RLAY
US75943R1023
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
15:56:51 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 19.56 USD | -5.67% |
|
-1.38% | +132.33% |
| 08-18 | Relay Therapeutics Insider Sold Shares Worth $349,734, According to a Recent SEC Filing | MT |
| 08-18 | Relay Therapeutics Insider Sold Shares Worth $979,886, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- RLAY Stock
- Consensus Relay Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
